Contact this trialFirst, we need to learn more about you.
Stem Cell Therapy
Stem Cell Therapy for Parkinson's Disease
Recruiting0 awardsPhase 2
Sugar Land, Texas
This trial is a phase 2 study testing the efficacy and safety of allogeneic HB-adMSCs vs Placebo for the treatment of Parkinson's disease. Up to 60 participants will be enrolled, with a screening period of up to 4 weeks, a 32- week treatment period, and a safety Follow-up period of 20 weeks after the last investigational product administration.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.